Insulet (PODD) Capital Expenditures (2010 - 2026)

Insulet (PODD) has 17 years of Capital Expenditures data on file, last reported at $10.1 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 17.89% year-over-year to $10.1 million; the trailing twelve-month figure through Mar 2026 stood at $17.0 million (down 85.23% YoY), and the FY2025 full-year result was $19.2 million, down 84.63% from the prior year.
• Capital Expenditures for Q1 2026 stood at $10.1 million, down from $16.1 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $53.6 million in Q4 2024 and bottomed at -$37.8 million in Q4 2023.
• The 5-year median for Capital Expenditures is $10.5 million (2023), against an average of $10.3 million.
• Peak annual rise in Capital Expenditures reached 617.86% in 2023, while the deepest fall reached 1612.0% in 2023.
• A 5-year view of Capital Expenditures shows it stood at $2.5 million in 2022, then plunged by 1612.0% to -$37.8 million in 2023, then jumped by 241.8% to $53.6 million in 2024, then tumbled by 69.96% to $16.1 million in 2025, then slumped by 37.27% to $10.1 million in 2026.
• The last three Capital Expenditures figures came in at $10.1 million (Q1 2026), $16.1 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.

Peer Comparison